Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $29.9600 (-1.45%) ($29.9600 - $29.9600) on Thu. Dec. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 20 | Latest Price | $29.9600(-1.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(62%) IWM(60%) | Factors Impacting EDIT price | EDIT will decline at least -2.085% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-12%) TBT(-8%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $16.49(-44.96%) | Resistance Level | $35.34 | 5 Day Moving Average | $31.32(-4.34%) | 10 Day Moving Average | $32.84(-8.77%) | 20 Day Moving Average | $35.34(-15.22%) | To recent high | -58.9% | To recent low | 0% | Market Cap | $1.861b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |